Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Rumi Nojiri
Observed name:
Nojiri, Rumi
Institution:
Maruishi Pharmaceutical (Japan)
Observed institution:
Maruishi Pharmaceutical (Japan)
ORCID:
0009-0003-7012-421X
Observed ORCID:
0009-0003-7012-421X
OpenAlex ID:
A5093254095
Efficacy, safety, and pharmacokinetics of MR13A11A, a generic of remifentanil, for pain management of Japanese patients in the intensive care unit: a double-blinded, fentanyl-controlled, randomized, non-inferiority phase 3 study
2023
·
Matsuyuki Doi
, Naoki Takahashi
, et al.
·
Journal of Intensive Care
·
16
PDF
Pharmacological, pharmacokinetic and clinical profiles of Difelikefalin (KORSUVA® IV Injection Syringe for Dialysis), a peripheral kappa opioid receptor agonist
2025
·
Keiichi Momotani
, Rumi Nojiri
, et al.
·
Folia Pharmacologica Japonica
·
3
PDF
Bridging the gap between mechanism and approval: Why 95% of analgesic trials fail to look beyond subjective scores and a proposal for change
2026
·
Aya Nakae
, Chie Kishimoto
, et al.
·
PAIN RESEARCH
PDF
Show more works
View as search
Works count:
5
Citation count:
19
H-index:
2
I10-index:
1
Year
Topic
Type